Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
Open Access
- 10 November 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (2), 290-292
- https://doi.org/10.2337/dc09-0681
Abstract
OBJECTIVE: To evaluate the heterogeneity in the clinical expression in a family with glucokinase mature-onset diabetes of the young (GCK-MODY). RESEARCH DESIGN AND METHODS: Members (three generations) of the same family presented either with overt neonatal hyperglycemia, marked postprandial hyperglycemia, or glucosuria. Homeostasis model assessment of insulin resistance (HOMAIR) and insulinogenic and disposition indexes were calculated. Oral glucose tolerance test (OGTT) results in the GCK mutation carriers from this family were compared with those from other subjects with GCK mutations in the same codon (GCK261), with other missense and other types of GCK mutations in different codons from the European MODY Consortium database (GCKm). RESULTS: Mutation G261R was found in the GCK gene. During the OGTT, glucose (P = 0.02) and insulin (P = 0.009) response at 2 h as well as at the 2-h glucose increment (GCK261 versus other missense GCK mutations, P = 0.003) were significantly higher in GCK261 than in GCKm carriers. CONCLUSIONS: Differing from other GCKm carriers, the glucose and insulin response to oral glucose was significantly higher in GCK261 carriers, indicating clinical heterogeneity in GCK-MODY.Keywords
This publication has 12 references indexed in Scilit:
- Assessing the potential of glucokinase activators in diabetes therapyNature Reviews Drug Discovery, 2009
- Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)Diabetes Care, 2008
- Clinical implications of a molecular genetic classification of monogenic β-cell diabetesNature Clinical Practice Endocrinology & Metabolism, 2008
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigreesDiabetologia, 2006
- Allosteric Activators of Glucokinase: Potential Role in Diabetes TherapyScience, 2003
- The genetic abnormality in the beta cell determines the response to an oral glucose loadDiabetologia, 2002
- Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasisDiabetologia, 1999
- Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.JCI Insight, 1997
- Familial Hyperglycemia Due to Mutations in Glucokinase -- Definition of a Subtype of Diabetes MellitusNew England Journal of Medicine, 1993